University Department of Medicine, Clinic for Endocrinology, Diabetology, and Metabolism, Kantonsspital Aarau, Aarau, Switzerland and Medical Faculty of the University of Basel, Basel, Switzerland.
Nutrition Science Group, The New York Academy of Sciences, New York.
JAMA Netw Open. 2019 Nov 1;2(11):e1915138. doi: 10.1001/jamanetworkopen.2019.15138.
Malnutrition affects a considerable proportion of the medical inpatient population. There is uncertainty regarding whether use of nutritional support during hospitalization in these patients positively alters their clinical outcomes.
To assess the association of nutritional support with clinical outcomes in medical inpatients who are malnourished or at nutritional risk.
For this updated systematic review and meta-analysis, a search of the Cochrane Library, MEDLINE, and Embase was conducted from January 1, 2015, to April 30, 2019; the included studies were published between 1982 and 2019.
A prespecified Cochrane protocol was followed to identify trials comparing oral and enteral nutritional support interventions with usual care and the association of these treatments with clinical outcomes in non-critically ill medical inpatients who were malnourished.
Two reviewers independently extracted data and assessed risk of bias; data were pooled using a random-effects model.
The primary outcome was mortality. The secondary outcomes included nonelective hospital readmissions, length of hospital stay, infections, functional outcome, daily caloric and protein intake, and weight change.
A total of 27 trials (n = 6803 patients) were included, of which 5 (n = 3067 patients) were published between 2015 and 2019. Patients receiving nutritional support compared with patients in the control group had significantly lower rates of mortality (230 of 2758 [8.3%] vs 307 of 2787 [11.0%]; odds ratio [OR], 0.73; 95% CI, 0.56-0.97). A sensitivity analysis suggested a more pronounced reduction in the risk of mortality in recent trials (2015 or later) (OR, 0.47; 95% CI, 0.28-0.79) compared with that in older studies (OR, 0.94; 95% CI, 0.72-1.22), in patients with established malnutrition (OR, 0.52; 95% CI, 0.34-0.80) compared with that in patients at nutritional risk (OR, 0.85; 95% CI, 0.62-1.18), and in trials with high protocol adherence (OR, 0.67; 95% CI, 0.54-0.84) compared with that in trials with low protocol adherence (OR, 0.88; 95% CI, 0.44-1.76). Nutritional support was also associated with a reduction in nonelective hospital readmissions (14.7% vs 18.0%; risk ratio, 0.76; 95% CI, 0.60-0.96), higher energy intake (mean difference, 365 kcal; 95% CI, 272-458 kcal) and protein intake (mean difference, 17.7 g; 95% CI, 12.1-23.3 g), and weight increase (0.73 kg; 95% CI, 0.32-1.13 kg). No significant differences were observed in rates of infections (OR, 0.86; 95% CI, 0.64-1.16), functional outcome (mean difference, 0.32; 95% CI, -0.51 to 1.15), and length of hospital stay (mean difference, -0.24; 95% CI, -0.58 to 0.09).
This study's findings suggest that despite heterogeneity and varying methodological quality among trials, nutritional support was associated with improved survival and nonelective hospital readmission rates among medical inpatients who were malnourished and should therefore be considered when treating this population.
营养不良影响了相当一部分住院患者。目前尚不确定这些患者在住院期间使用营养支持是否会对其临床结局产生积极影响。
评估营养支持与营养不良或存在营养风险的住院内科患者的临床结局之间的关系。
本更新的系统评价和荟萃分析检索了 Cochrane 图书馆、MEDLINE 和 Embase,检索时间为 2015 年 1 月 1 日至 2019 年 4 月 30 日;纳入的研究发表于 1982 年至 2019 年。
遵循预先制定的 Cochrane 方案,以确定比较口服和肠内营养支持干预与常规护理的试验,并评估这些治疗方法与非重症住院内科患者营养不良相关的临床结局之间的关系。
两名审查员独立提取数据并评估偏倚风险;使用随机效应模型汇总数据。
主要结局是死亡率。次要结局包括非选择性住院再入院、住院时间、感染、功能结局、每日热量和蛋白质摄入以及体重变化。
共纳入 27 项试验(n=6803 名患者),其中 5 项(n=3067 名患者)发表于 2015 年至 2019 年。与对照组相比,接受营养支持的患者死亡率显著降低(230/2758 [8.3%] 与 307/2787 [11.0%];比值比[OR],0.73;95%置信区间[CI],0.56-0.97)。敏感性分析表明,与较旧的研究相比(OR,0.94;95%CI,0.72-1.22),最近的试验(2015 年或之后)(OR,0.47;95%CI,0.28-0.79)中死亡率的降低更为明显,在已确定存在营养不良的患者(OR,0.52;95%CI,0.34-0.80)与存在营养风险的患者(OR,0.85;95%CI,0.62-1.18)之间,在高方案依从性的试验(OR,0.67;95%CI,0.54-0.84)与低方案依从性的试验(OR,0.88;95%CI,0.44-1.76)之间。营养支持也与非选择性住院再入院率降低相关(14.7% 与 18.0%;风险比[RR],0.76;95%CI,0.60-0.96)、更高的能量摄入(平均差异,365 千卡;95%CI,272-458 千卡)和蛋白质摄入(平均差异,17.7 克;95%CI,12.1-23.3 克)以及体重增加(0.73 千克;95%CI,0.32-1.13 千克)。在感染率(OR,0.86;95%CI,0.64-1.16)、功能结局(平均差异,0.32;95%CI,-0.51 至 1.15)和住院时间(平均差异,-0.24;95%CI,-0.58 至 0.09)方面,没有观察到显著差异。
本研究结果表明,尽管试验存在异质性和不同的方法学质量,但营养支持与营养不良住院内科患者的生存率和非选择性住院再入院率提高相关,因此在治疗该人群时应考虑使用。